Is ADHD overdiagnosed? Yes, but only for certain groups of children.
The most comprehensive review on this question—a systematic scoping review of 334 studies—found substantial evidence that ADHD is overdiagnosed and overtreated in children and adolescents [5]. The review showed that diagnosis rates have risen, that many new cases are on the milder end of the symptom spectrum, and that for these milder cases, the harms of medication may outweigh the benefits [5]. But this doesn't mean every child diagnosed with ADHD doesn't have it. The overdiagnosis is concentrated in specific groups.
A large U.S. study of over 238,000 children found that white children were significantly more likely to be diagnosed with ADHD than Black, Hispanic, or Asian children, even after adjusting for income and region [1]. Another study of 1,070 elementary school children who had above-average functioning (making ADHD unlikely) found that white children were 1.7 to 2.6 times more likely to be diagnosed and 1.7 to 2.4 times more likely to be put on medication than non-white children with the same low-risk profile [2]. This means that for white children with mild symptoms, overdiagnosis is a real risk, while minority children with the same symptoms are more likely to be missed.
Boys are more likely to be overdiagnosed than girls, and cultural context matters.
Gender plays a clear role. A study of 344 Iranian psychiatrists presented with identical case vignettes of children with and without ADHD found that overdiagnosis occurred for both boys and girls, but it was 2.45 times more likely for boys [7]. This suggests that clinicians may be more primed to see ADHD in boys, leading to diagnostic errors. The study also found that overdiagnosis directly led to more medication prescriptions [7].
Cultural context also shifts the picture. In the U.S., Asian children had the lowest diagnosis rates (hazard ratio 0.48 compared to white children) and the highest odds of receiving no treatment at all [1]. In Iran, overdiagnosis was still common, but the pattern was different—boys were overdiagnosed more than girls, regardless of the psychiatrist's own gender [7]. These findings show that overdiagnosis isn't a single global problem; it's shaped by who the child is and where they are evaluated.
Underdiagnosis is a serious problem for many children, especially those with other conditions.
While overdiagnosis gets headlines, underdiagnosis is equally concerning. Children with hearing loss, for example, had ADHD rates of 12.1% compared to 3.6% in children with normal hearing—but after accounting for other conditions like autism, the difference disappeared [3]. This suggests that ADHD may be missed in children with complex medical histories if clinicians attribute attention problems to the other condition. Similarly, among children with multiple sclerosis, 47% had ADHD, yet many were likely undiagnosed before the study [4].
The ADHD Assessment Quality Assurance Standard (CAAQAS), a 2024 expert consensus, was created precisely to reduce both overdiagnosis and underdiagnosis by promoting thorough, multi-source assessments [6]. The standard emphasizes that a proper diagnosis requires gathering information from parents, teachers, and medical records, and assessing for co-occurring conditions. Without this rigor, clinicians risk either overdiagnosing mild cases in white boys or underdiagnosing ADHD in girls, minority children, and those with other medical conditions.
About These Sources
This answer is built on 7 peer-reviewed studies — published from 2021 to 2024, 2 from 2024 or later, 4 in Q1 journals, collectively cited 335 times — selected as the most relevant from 13 studies that passed quality screening, drawn from 40 papers retrieved from a database of over 500 million.
Sources used in this answer
Racial Disparities in Diagnosis of Attention-Deficit/Hyperactivity Disorder in a US National Birth Cohort
In a U.S. national cohort of 238,011 children, white children had significantly higher ADHD diagnosis rates than Black, Hispanic, and Asian children after adjusting for sex, region, and income; Asian children had the lowest rates and highest odds of receiving no treatment.
Sociodemographic Disparities in Attention-Deficit/Hyperactivity Disorder Overdiagnosis and Overtreatment During Elementary School
Among 1,070 U.S. elementary school children with above-average functioning (making ADHD unlikely), white children were 1.7–2.6 times more likely to be diagnosed and 1.7–2.4 times more likely to be medicated than non-white children, indicating overdiagnosis in white children.
Attention-deficit/hyperactivity disorder in children with hearing loss.
In a retrospective cohort of 919 children, ADHD rates were higher in children with hearing loss (12.1%) than normal hearing (3.6%), but after adjusting for comorbidities like autism, the difference disappeared, suggesting underdiagnosis in children with complex conditions.
Attention Deficit/Hyperactivity Disorder in Children with Multiple Sclerosis.
In a retrospective review of 66 children with pediatric-onset multiple sclerosis, 47% had ADHD, and 44% had cognitive impairment, highlighting that ADHD is common but likely underdiagnosed in this population.
Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
A systematic scoping review of 334 studies found evidence of ADHD overdiagnosis and overtreatment in children and adolescents, especially for milder cases where harms may outweigh benefits.
The ADHD Assessment Quality Assurance Standard for Children and Teenagers (CAAQAS)
An expert consensus (CAAQAS) proposes quality standards for ADHD assessments in children to reduce overdiagnosis, misdiagnosis, and underdiagnosis, emphasizing multi-source information and assessment of comorbidities.
ADHD overdiagnosis and the role of patient gender among Iranian psychiatrists
In a vignette study of 344 Iranian psychiatrists, overdiagnosis of ADHD occurred for both genders but was 2.45 times more likely for boys, and overdiagnosis directly increased medication prescriptions.